Contract with Customer, Liability, Current in USD of LIFECORE BIOMEDICAL, INC. \DE\ from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly Contract with Customer, Liability, Current history and change rate from Q2 2018 to Q3 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Contract with Customer, Liability, Current for the quarter ending 30 Sep 2025 was $7.21M.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $7.21M 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $5.2M +$3.08M +146% 30 Jun 2025 10-Q 06 Nov 2025
Q1 2025 $2.57M -$635K -19.8% 23 Feb 2025 10-Q 03 Apr 2025
Q2 2024 $2.11M -$1.99M -48.5% 26 May 2024 10-K 07 Aug 2025
Q1 2024 $3.2M +$489K +18% 25 Feb 2024 10-Q 09 Aug 2024
Q4 2023 $8.3M +$7.57M +1035% 26 Nov 2023 10-Q 09 Aug 2024
Q3 2023 $8.3M +$7.5M +934% 27 Aug 2023 10-Q 09 Aug 2024
Q2 2023 $4.1M +$3.18M +346% 28 May 2023 10-Q 09 Aug 2024
Q1 2023 $2.71M +$1.1M +68% 26 Feb 2023 10-K 20 Mar 2024
Q4 2022 $731K -$236K -24.4% 27 Nov 2022 10-K 20 Mar 2024
Q3 2022 $803K -$266K -24.9% 28 Aug 2022 10-K 20 Mar 2024
Q2 2022 $919K +$632K +220% 29 May 2022 10-K 20 Mar 2024
Q1 2022 $1.61M +$874K +118% 27 Feb 2022 10-K 20 Mar 2024
Q4 2021 $967K +$670K +226% 28 Nov 2021 10-K 20 Mar 2024
Q3 2021 $1.07M +$1.07M 29 Aug 2021 10-K 20 Mar 2024
Q2 2021 $287K -$65K -18.5% 30 May 2021 10-K 20 Mar 2024
Q1 2021 $740K +$122K +19.7% 28 Feb 2021 10-K 20 Mar 2024
Q4 2020 $297K -$314K -51.4% 29 Nov 2020 10-K 20 Mar 2024
Q3 2020 $0 -$488K -100% 30 Aug 2020 10-K 20 Mar 2024
Q2 2020 $352K -$147K -29.5% 31 May 2020 10-K 29 Jul 2021
Q1 2020 $618K -$668K -51.9% 23 Feb 2020 10-Q 03 Apr 2020
Q4 2019 $611K -$1.11M -64.4% 24 Nov 2019 10-Q 02 Jan 2020
Q3 2019 $488K 25 Aug 2019 10-Q 03 Oct 2019
Q2 2019 $499K -$2.13M -81% 26 May 2019 10-K 14 Aug 2020
Q1 2019 $1.29M 24 Feb 2019 10-Q 04 Apr 2019
Q4 2018 $1.72M 25 Nov 2018 10-Q 07 Jan 2019
Q2 2018 $2.63M 27 May 2018 10-K 01 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.